癌症中circRNAs和miR-141之间的相互作用:从发病到诊断和治疗
Małgorzata Guz1, Witold Jeleniewicz1, Marek Cybulski1
1Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
International journal of molecular sciences
|July 29, 2023
概括
循环RNAs (circRNAs) 和微RNAs (miRNAs) 是癌症发展的关键. 这项研究回顾了circRNA/miR-141相互作用,突出了它们在癌症中的作用和潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 非编码RNAs (ncRNAs),包括循环RNAs (circRNAs) 和microRNAs (miRNAs),是癌症发病的组成部分.
- 异常的ncRNA表达驱动致癌,circRNAs在竞争的内源性RNA (ceRNA) 网络中起到关键的调节作用.
- 循环RNAs作为miRNA海绵起作用,调节miRNA对mRNA点的可访问性,并影响细胞平衡.
研究的目的:
- 审查目前对恶性转变中circRNA和miR-141相互作用的理解.
- 强调circRNA/miR-141/mRNA网络在癌症中的生物学作用.
- 探索这些网络作为新型抗癌治疗点的潜力.
主要方法:
- 文献综述和对circRNA-miRNA相互作用现有研究的综合.
- 对涉及circRNAs,miR-141及其mRNA目标的分子机制的分析.
- 专注于ceRNA网络在癌症生物学中的作用.
主要成果:
- 循环RNA作为miRNA海绵,circRNA/miRNA相互作用的不平衡导致各种病理,特别是癌症.
- 与miR-141 (miR-200家族成员) 的特定circRNA相互作用与恶性转变有关.
- 环RNA/miR-141/mRNA调节网络在癌症发展中发挥着重要作用.
结论:
- 环RNA/miR-141轴是癌症生物学的一个关键组成部分.
- 了解这些分子相互作用为癌症发生提供了洞察力.
- 针对circRNA/miR-141/mRNA网络为未来的抗癌疗法提供了有希望的途径.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K